{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:15:35Z","timestamp":1790392535424,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDTCNSND"],"published-print":{"date-parts":[[2004,8,1]]},"DOI":"10.2174\/1568007043337166","type":"journal-article","created":{"date-parts":[[2005,3,17]],"date-time":"2005-03-17T23:24:15Z","timestamp":1111101855000},"page":"325-332","source":"Crossref","is-referenced-by-count":50,"title":["The MAPK \/ JNK Signalling Pathway Offers Potential Therapeutic Targets for the Prevention of Acquired Deafness"],"prefix":"10.2174","volume":"3","author":[{"given":"A.","family":"Zine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Water","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Drug Target -CNS & Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/90890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T05:02:23Z","timestamp":1448254943000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-007X&volume=3&issue=4&spage=325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,1]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568007043337166","relation":{},"ISSN":["1568-007X"],"issn-type":[{"value":"1568-007X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8,1]]}}}